Ingram G - Search Results

1

COVID-19 Vaccine Response in People with Multiple Sclerosis.

Tallantyre EC, Vickaryous N, Anderson V, Asardag AN, Baker D, Bestwick J, Bramhall K, Chance R, Evangelou N, George K, Giovannoni G, Godkin A, Grant L, Harding KE, Hibbert A, Ingram G, Jones M, Kang AS, Loveless S, Moat SJ, Robertson NP, Schmierer K, Scurr MJ, Shah SN, Simmons J, Upcott M, Willis M, Jolles S, Dobson R. Tallantyre EC, et al. Among authors: ingram g. Ann Neurol. 2022 Jan;91(1):89-100. doi: 10.1002/ana.26251. Epub 2021 Nov 17. Ann Neurol. 2022. PMID: 34687063 Free PMC article.

2

Contribution of relapses to disability in multiple sclerosis.

Hirst C, Ingram G, Pearson O, Pickersgill T, Scolding N, Robertson N. Hirst C, et al. Among authors: ingram g. J Neurol. 2008 Feb;255(2):280-7. doi: 10.1007/s00415-008-0743-8. Epub 2008 Jan 23. J Neurol. 2008. PMID: 18204919

3

Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis.

Hirst C, Ingram G, Swingler R, Compston DA, Pickersgill T, Robertson NP. Hirst C, et al. Among authors: ingram g. J Neurol Neurosurg Psychiatry. 2008 Oct;79(10):1137-43. doi: 10.1136/jnnp.2007.133785. Epub 2008 Feb 26. J Neurol Neurosurg Psychiatry. 2008. PMID: 18303106

4

Increasing prevalence and incidence of multiple sclerosis in South East Wales.

Hirst C, Ingram G, Pickersgill T, Swingler R, Compston DA, Robertson NP. Hirst C, et al. Among authors: ingram g. J Neurol Neurosurg Psychiatry. 2009 Apr;80(4):386-91. doi: 10.1136/jnnp.2008.144667. Epub 2008 Oct 17. J Neurol Neurosurg Psychiatry. 2009. PMID: 18931003

5

Complement in multiple sclerosis: its role in disease and potential as a biomarker.

Ingram G, Hakobyan S, Robertson NP, Morgan BP. Ingram G, et al. Clin Exp Immunol. 2009 Feb;155(2):128-39. doi: 10.1111/j.1365-2249.2008.03830.x. Epub 2008 Nov 24. Clin Exp Immunol. 2009. PMID: 19040603 Free PMC article. Review.

6

Very long chain fatty acid levels in patients diagnosed with multiple sclerosis.

Wilkins A, Ingram G, Brown A, Jardine P, Steward CG, Robertson NP, Scolding NJ. Wilkins A, et al. Among authors: ingram g. Mult Scler. 2009 Dec;15(12):1525-7. doi: 10.1177/1352458509351731. Epub 2009 Nov 13. Mult Scler. 2009. PMID: 19965514

7

Validity of patient-derived disability and clinical data in multiple sclerosis.

Ingram G, Colley E, Ben-Shlomo Y, Cossburn M, Hirst CL, Pickersgill TP, Robertson NP. Ingram G, et al. Mult Scler. 2010 Apr;16(4):472-9. doi: 10.1177/1352458509358902. Epub 2010 Feb 11. Mult Scler. 2010. PMID: 20150395

8

Elevated plasma C4a levels in multiple sclerosis correlate with disease activity.

Ingram G, Hakobyan S, Robertson NP, Morgan BP. Ingram G, et al. J Neuroimmunol. 2010 Jun;223(1-2):124-7. doi: 10.1016/j.jneuroim.2010.03.014. Epub 2010 Apr 20. J Neuroimmunol. 2010. PMID: 20409594

9

Complement regulator factor H as a serum biomarker of multiple sclerosis disease state.

Ingram G, Hakobyan S, Hirst CL, Harris CL, Pickersgill TP, Cossburn MD, Loveless S, Robertson NP, Morgan BP. Ingram G, et al. Brain. 2010 Jun;133(Pt 6):1602-11. doi: 10.1093/brain/awq085. Epub 2010 Apr 25. Brain. 2010. PMID: 20421219

10

Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity.

Ingram G, Bugert JJ, Loveless S, Robertson NP. Ingram G, et al. Eur J Neurol. 2010 Nov;17(11):1386-9. doi: 10.1111/j.1468-1331.2010.03083.x. Eur J Neurol. 2010. PMID: 20482607

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

351 results

Search Page